Exit Notice
You are about to leave ClinicalTrials.gov and go to: To obtain contact information for a study center near you, click here. URL: https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1931008&StudyName=%20A%20Study%20Of%20Inotuzumab%20Ozogamicin%20Plus%20Rituximab%20For%20Relapsed/Refractory%20Aggressive%20Non-Hodgkin%20Lymphoma%20Patients%20Who%20Are%20Not%20Candidates%20F
Click on the link to continue or return to ClinicalTrials.gov Home